You BETer be aware – Learnings from a negative phase 1 study

Sophie Postel-Vinay, Matthias Ocker

Résultats de recherche: Contribution à un journal › Editorial

Autres fichiers et liens

@article{cceb314f4bc64374a400ae393279b021,

title = "You BETer be aware – Learnings from a negative phase 1 study",

keywords = "BET inhibitor, Epigenetics, Modelling, Phase 1, Toxicity",

author = "Sophie Postel-Vinay and Matthias Ocker",

year = "2019",

month = may,

day = "1",

language = "English",

volume = "10",

pages = "3145--3146",

journal = "Oncotarget",

issn = "1949-2553",

number = "34",

}

TY - JOUR

T1 - You BETer be aware – Learnings from a negative phase 1 study

AU - Postel-Vinay, Sophie

AU - Ocker, Matthias

PY - 2019/5/1

Y1 - 2019/5/1

KW - BET inhibitor

KW - Epigenetics

KW - Modelling

KW - Phase 1

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85065838254&partnerID=8YFLogxK

M3 - Editorial

C2 - 31139327

AN - SCOPUS:85065838254

SN - 1949-2553

VL - 10

SP - 3145

EP - 3146

JO - Oncotarget

JF - Oncotarget

IS - 34

ER -